SLC31A1 and neoplasm: In 2014, Counter Research Group (9)confirmed downregulating the expression of CTR1 may influence the combination of MEK1 and copper, thereby inhibiting ERK signaling pathway mediated by BRAF and ultimatingly suppressing the tumor growth.